NO854942L - Fremgangsmaate for fremstilling av terapeutisk aktive, benzotiofener og benzofuraner. - Google Patents
Fremgangsmaate for fremstilling av terapeutisk aktive, benzotiofener og benzofuraner.Info
- Publication number
- NO854942L NO854942L NO854942A NO854942A NO854942L NO 854942 L NO854942 L NO 854942L NO 854942 A NO854942 A NO 854942A NO 854942 A NO854942 A NO 854942A NO 854942 L NO854942 L NO 854942L
- Authority
- NO
- Norway
- Prior art keywords
- benzotiophenes
- benzofuranes
- procedure
- preparation
- therapeutic active
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D307/92—Naphthofurans; Hydrogenated naphthofurans
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D407/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00
- C07D407/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings
- C07D407/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C323/00—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D307/78—Benzo [b] furans; Hydrogenated benzo [b] furans
- C07D307/82—Benzo [b] furans; Hydrogenated benzo [b] furans with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the hetero ring
- C07D307/84—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
- C07D307/85—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 2
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D307/78—Benzo [b] furans; Hydrogenated benzo [b] furans
- C07D307/86—Benzo [b] furans; Hydrogenated benzo [b] furans with an oxygen atom directly attached in position 7
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
- C07D333/50—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
- C07D333/52—Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes
- C07D333/62—Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the hetero ring
- C07D333/68—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
- C07D333/70—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 2
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/04—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D407/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00
- C07D407/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings
- C07D407/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Immunology (AREA)
- Engineering & Computer Science (AREA)
- Pulmonology (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Furan Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US68010884A | 1984-12-10 | 1984-12-10 | |
| US06/790,664 US4703053A (en) | 1985-10-28 | 1985-10-28 | Benzothiophenes and benzofurans and antiallergic use thereof |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| NO854942L true NO854942L (no) | 1986-06-11 |
| NO165592B NO165592B (no) | 1990-11-26 |
| NO165592C NO165592C (no) | 1991-03-06 |
Family
ID=27102392
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO854942A NO165592C (no) | 1984-12-10 | 1985-12-09 | Analogifremgangsmaate for fremstilling av terapeutisk aktive benzotiofener og benzofuraner. |
Country Status (17)
| Country | Link |
|---|---|
| EP (1) | EP0187487B1 (no) |
| JP (1) | JPH0819125B2 (no) |
| KR (1) | KR890000009B1 (no) |
| CN (1) | CN1007153B (no) |
| AU (1) | AU579291B2 (no) |
| CA (1) | CA1261848A (no) |
| DE (1) | DE3579434D1 (no) |
| DK (1) | DK169326B1 (no) |
| ES (3) | ES8708225A1 (no) |
| FI (1) | FI80691C (no) |
| GR (1) | GR852949B (no) |
| HK (1) | HK77393A (no) |
| IE (1) | IE58555B1 (no) |
| NO (1) | NO165592C (no) |
| NZ (1) | NZ214479A (no) |
| PT (1) | PT81636B (no) |
| SG (1) | SG59593G (no) |
Families Citing this family (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4675332A (en) * | 1984-12-10 | 1987-06-23 | Warner-Lambert Company | Acidic tetrazolyl substituted indole compounds and their use as antiallergy agents |
| US4748183A (en) * | 1986-06-13 | 1988-05-31 | Warner-Lambert Company | N-1H-tetrazol-5-yl-2-thiophene carboxamides, N-1H-tetrazol-5-yl-2-pyrrole carboxamides, N-1H-tetrazol-5-yl-2-furan carboxamides, and anti-allergic and anti-inflammatory use thereof |
| EP0253650A3 (en) * | 1986-07-18 | 1989-09-13 | Eli Lilly And Company | Improvements relating to benzothiophene derivatives |
| US4800211A (en) * | 1986-08-18 | 1989-01-24 | Merck & Co., Inc. | 5-methylthio-3-hydroxybenzo [b]thiophene-2-carboxamide derivatives as cyclooxygenase and lipoxygenase inhibitors |
| US4910317A (en) * | 1987-07-14 | 1990-03-20 | Warner-Lambert Company | Benzofurans and benzothiophenes having antiallergic activity and method of use thereof |
| IE64995B1 (en) * | 1987-07-14 | 1995-09-20 | Warner Lambert Co | Novel benzothiophenes having antiallergic activity and both novel and other selected benzothiophenes having activity for treating acute respiratory distress syndrome |
| AT387966B (de) * | 1987-10-08 | 1989-04-10 | Warner Lambert Co | Neue n-1h-tetrazol-5-yl-(5-ring)-carboxamidderivate sowie verwendung derartiger verbindungen |
| US5093351A (en) * | 1989-01-05 | 1992-03-03 | Du Pont Merck Pharmaceutical Company | Substituted indole, benzofuran and benzothiophene derivatives as 5-lipoxygenase inhibitors |
| IT1228893B (it) * | 1989-02-24 | 1991-07-09 | Valeas Spa | Derivati tetrazol ammidici di acidi alchenil eterociclici e loroimpiego come sostanze antiallergiche |
| DE4126999A1 (de) * | 1991-08-16 | 1993-02-18 | Basf Ag | Herbizide mittel, enthaltend 3-aminobenzo(b)thiophene als antidots |
| DE4128871A1 (de) * | 1991-08-30 | 1993-03-04 | Boehringer Mannheim Gmbh | Benzo(b)thiophenderivate, verfahren zu ihrer herstellung und arzneimittel |
| US5426191A (en) * | 1993-12-03 | 1995-06-20 | Warner-Lambert Company | Process for the synthesis of 3-chlorobenzo[b]thiophene-2-carbonyl chlorides |
| JP2006526608A (ja) * | 2003-06-05 | 2006-11-24 | ワーナー−ランバート カンパニー リミティド ライアビリティー カンパニー | Ｐｉ３ｋ活性を有する治療薬としてのテトラゾールベンゾフランカルボキシアミド |
| JP2006526606A (ja) * | 2003-06-05 | 2006-11-24 | ワーナー−ランバート カンパニー リミティド ライアビリティー カンパニー | 治療薬としてのシクロアルキル及びヘテロシクロアルキル置換されるベンゾチオフェン |
| ATE365735T1 (de) * | 2003-06-05 | 2007-07-15 | Warner Lambert Co | Cycloalkylsulfanyl-substituierte benzo böthiophene als therapeutische mittel |
| MXPA05012953A (es) * | 2003-06-05 | 2006-02-13 | Warner Lambert Co | Benzo[b]tiofenos 3-arilsulfanil y 3-heteroarilsulfanil sustituidos como agentes terapeuticos. |
| EP1664037A1 (en) * | 2003-09-04 | 2006-06-07 | Warner-Lambert Company Llc | Halo substituted benzo [b] thiophenes with pi3k inhibitory activity as therapeutic agents |
| EP4213832A4 (en) * | 2020-09-18 | 2024-10-16 | Merck Sharp & Dohme Llc | MODIFIED BENZOFURANCARBOXAMIDES AS GLUCOSYLCERAMIDE SYNTHASE INHIBITORS |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3452039A (en) * | 1966-05-25 | 1969-06-24 | Bristol Myers Co | Certain 5-tetrazolyl benzothiophene compounds |
| US4432986A (en) * | 1979-06-18 | 1984-02-21 | Riker Laboratories, Inc. | Tetrazoles bonded to certain polycyclic aromatic systems and anti-allergic use thereof |
| EP0146243A1 (en) * | 1983-10-31 | 1985-06-26 | Merck Frosst Canada Inc. | Lipoxygenase inhibitors |
| GB8406906D0 (en) * | 1984-03-16 | 1984-04-18 | Akzo Nv | Benzo-thiazole and benzothiophene derivatives |
| FR2584723B1 (fr) * | 1985-07-09 | 1988-02-12 | Adir | Nouveaux derives du dihydro-2,3 benzofuranne, leurs procedes de preparation et les compositions pharmaceutiques qui les contiennent |
-
1985
- 1985-11-13 IE IE284485A patent/IE58555B1/en not_active IP Right Cessation
- 1985-11-29 AU AU50505/85A patent/AU579291B2/en not_active Expired
- 1985-12-05 CA CA000496926A patent/CA1261848A/en not_active Expired
- 1985-12-09 FI FI854854A patent/FI80691C/fi not_active IP Right Cessation
- 1985-12-09 DK DK568685A patent/DK169326B1/da not_active IP Right Cessation
- 1985-12-09 GR GR852949A patent/GR852949B/el not_active IP Right Cessation
- 1985-12-09 NO NO854942A patent/NO165592C/no not_active IP Right Cessation
- 1985-12-09 NZ NZ214479A patent/NZ214479A/xx unknown
- 1985-12-10 PT PT81636A patent/PT81636B/pt unknown
- 1985-12-10 CN CN85109587A patent/CN1007153B/zh not_active Expired
- 1985-12-10 ES ES549769A patent/ES8708225A1/es not_active Expired
- 1985-12-10 EP EP85308947A patent/EP0187487B1/en not_active Expired - Lifetime
- 1985-12-10 KR KR1019850009254A patent/KR890000009B1/ko not_active IP Right Cessation
- 1985-12-10 DE DE8585308947T patent/DE3579434D1/de not_active Expired - Lifetime
-
1987
- 1987-01-16 ES ES557333A patent/ES8802453A1/es not_active Expired
- 1987-01-16 ES ES557334A patent/ES8801284A1/es not_active Expired
-
1993
- 1993-05-05 SG SG595/93A patent/SG59593G/en unknown
- 1993-07-29 HK HK773/93A patent/HK77393A/xx not_active IP Right Cessation
-
1994
- 1994-06-01 JP JP6119894A patent/JPH0819125B2/ja not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| EP0187487A1 (en) | 1986-07-16 |
| CN1007153B (zh) | 1990-03-14 |
| DK169326B1 (da) | 1994-10-10 |
| FI854854A (fi) | 1986-06-11 |
| EP0187487B1 (en) | 1990-08-29 |
| FI854854A0 (fi) | 1985-12-09 |
| KR860004885A (ko) | 1986-07-14 |
| AU5050585A (en) | 1986-06-19 |
| FI80691C (fi) | 1990-07-10 |
| SG59593G (en) | 1993-07-09 |
| ES557333A0 (es) | 1988-06-01 |
| FI80691B (fi) | 1990-03-30 |
| PT81636B (pt) | 1988-02-17 |
| KR890000009B1 (ko) | 1989-03-02 |
| CA1261848A (en) | 1989-09-26 |
| AU579291B2 (en) | 1988-11-17 |
| IE58555B1 (en) | 1993-10-06 |
| DK568685D0 (da) | 1985-12-09 |
| NZ214479A (en) | 1989-08-29 |
| ES549769A0 (es) | 1987-10-01 |
| NO165592B (no) | 1990-11-26 |
| HK77393A (en) | 1993-08-06 |
| DE3579434D1 (de) | 1990-10-04 |
| IE852844L (en) | 1986-06-10 |
| ES8802453A1 (es) | 1988-06-01 |
| CN85109587A (zh) | 1986-12-17 |
| PT81636A (en) | 1986-01-01 |
| ES8801284A1 (es) | 1987-12-16 |
| JPH07149763A (ja) | 1995-06-13 |
| GR852949B (no) | 1986-04-10 |
| ES557334A0 (es) | 1987-12-16 |
| NO165592C (no) | 1991-03-06 |
| JPH0819125B2 (ja) | 1996-02-28 |
| ES8708225A1 (es) | 1987-10-01 |
| DK568685A (da) | 1986-06-11 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO884154D0 (no) | Fremgangsmaate for fremstilling av terapeutisk aktive preparater. | |
| NO164025C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive 3-imidazolylmetyl-tetrahydrokarbazolon-derivater. | |
| NO874869D0 (no) | Fremgangsmaate for fremstilling av terapeutisk aktive forbindelser. | |
| NO853046L (no) | Fremgangsmaate for fremstilling av terapeutisk aktive indol-derivater. | |
| NO852885L (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive naftyridin-, kinolon- og pyridobenzoksazin-derivater. | |
| NO162238C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive 1,4-dihydro-4-oksonaftyridinderivater. | |
| NO854942L (no) | Fremgangsmaate for fremstilling av terapeutisk aktive, benzotiofener og benzofuraner. | |
| NO157146C (no) | Analogifremgangsmaate ved fremstilling av terapeutisk, aktive derivater av morfolinyl-daunorbicin og morfolinyl-doksorubicin. | |
| NO884638D0 (no) | Fremgangsmaate for fremstilling av terapeutisk aktive tetraliner, kromaner og beslektede forbindelser. | |
| NO161497C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive 9a-aza-9a-homoerytromycin-derivater. | |
| NO864674D0 (no) | Fremgangsmaate for fremstilling av terapeutisk aktive cefemforbindelser. | |
| NO871588L (no) | Fremgangsmaate for fremstilling av terapeutisk aktive heterocykliske karboksamider. | |
| NO862373D0 (no) | Fremgangsmaate for fremstilling av terapeutisk aktive tienopyridoner. | |
| NO883750L (no) | Fremgangsmaate for fremstilling av terapeutisk aktive piperidinderivater. | |
| NO164541C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive benzimidazolderivater. | |
| NO158460C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive forbindelser. | |
| NO164897C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive oxazolidinonderivater. | |
| NO862534D0 (no) | Analogifremgangsmaate for fremstilling av terapeutisk virksomme 2-oxy-4h-3,1-benzoxazin-4-on-derivater og beslektede forbindelser. | |
| NO861584L (no) | Fremgangsmaate til fremstilling av terapeutisk aktive cyklopentyletere. | |
| NO169067C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive 3-karbonyl-1-aminoalkyl-1h-indoler, og mellomprodukter | |
| NO162188C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive imidazokinoliner. | |
| NO162072C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive tienopyridinderivater. | |
| NO165542C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive 5-aryl-2,4-dialkyl-3h-1,2,4-triazol-3-thioner. | |
| NO882281D0 (no) | Fremgangsmaate for fremstilling av terapeutisk aktive pyrazinamider. | |
| NO892871D0 (no) | Fremgangsmaate for fremstilling av terapeutisk aktive forbindelser. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MK1K | Patent expired |